Global Pediatric Medicines Market Insights and Forecast to 2026

Publisher Name :
Date: 10-Jul-2020
No. of pages: 114
Inquire Before Buying

Pediatric Medicines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Pediatric Medicines market is segmented into

- Enteral

- Parenteral

- Topical

Segment by Application, the Pediatric Medicines market is segmented into

- Hospital

- Clinic

- Family

Regional and Country-level Analysis

The Pediatric Medicines market is analysed and market size information is provided by regions (countries).

The key regions covered in the Pediatric Medicines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Pediatric Medicines Market Share Analysis

Pediatric Medicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pediatric Medicines business, the date to enter into the Pediatric Medicines market, Pediatric Medicines product introduction, recent developments, etc.

The major vendors covered:

- GSK

- Novartis

- Pfizer

- Sanofi

- Abbott

- Bristol-Myers Squibb

- Cipla

- Eisai Pharmaceuticals

- Eli Lilly

- F. Hoffman-La Roche

- Glenmark

- Helsinn Healthcare

- Heron Therapeutics

- Ipca Laboratories

Global Pediatric Medicines Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pediatric Medicines Product Introduction
1.2 Market Segments
1.3 Key Pediatric Medicines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pediatric Medicines Market Size Growth Rate by Type
1.4.2 Enteral
1.4.3 Parenteral
1.4.4 Topical
1.5 Market by Application
1.5.1 Global Pediatric Medicines Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Family
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Medicines Market Size, Estimates and Forecasts
2.1.1 Global Pediatric Medicines Revenue 2015-2026
2.1.2 Global Pediatric Medicines Sales 2015-2026
2.2 Global Pediatric Medicines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pediatric Medicines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pediatric Medicines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pediatric Medicines Competitor Landscape by Players
3.1 Pediatric Medicines Sales by Manufacturers
3.1.1 Pediatric Medicines Sales by Manufacturers (2015-2020)
3.1.2 Pediatric Medicines Sales Market Share by Manufacturers (2015-2020)
3.2 Pediatric Medicines Revenue by Manufacturers
3.2.1 Pediatric Medicines Revenue by Manufacturers (2015-2020)
3.2.2 Pediatric Medicines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pediatric Medicines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pediatric Medicines Revenue in 2019
3.2.5 Global Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pediatric Medicines Price by Manufacturers
3.4 Pediatric Medicines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Medicines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Medicines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Medicines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatric Medicines Market Size by Type (2015-2020)
4.1.1 Global Pediatric Medicines Sales by Type (2015-2020)
4.1.2 Global Pediatric Medicines Revenue by Type (2015-2020)
4.1.3 Pediatric Medicines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pediatric Medicines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pediatric Medicines Sales Forecast by Type (2021-2026)
4.2.2 Global Pediatric Medicines Revenue Forecast by Type (2021-2026)
4.2.3 Pediatric Medicines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pediatric Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pediatric Medicines Market Size by Application (2015-2020)
5.1.1 Global Pediatric Medicines Sales by Application (2015-2020)
5.1.2 Global Pediatric Medicines Revenue by Application (2015-2020)
5.1.3 Pediatric Medicines Price by Application (2015-2020)
5.2 Pediatric Medicines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pediatric Medicines Sales Forecast by Application (2021-2026)
5.2.2 Global Pediatric Medicines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pediatric Medicines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pediatric Medicines by Country
6.1.1 North America Pediatric Medicines Sales by Country
6.1.2 North America Pediatric Medicines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pediatric Medicines Market Facts & Figures by Type
6.3 North America Pediatric Medicines Market Facts & Figures by Application
7 Europe
7.1 Europe Pediatric Medicines by Country
7.1.1 Europe Pediatric Medicines Sales by Country
7.1.2 Europe Pediatric Medicines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pediatric Medicines Market Facts & Figures by Type
7.3 Europe Pediatric Medicines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pediatric Medicines by Region
8.1.1 Asia Pacific Pediatric Medicines Sales by Region
8.1.2 Asia Pacific Pediatric Medicines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pediatric Medicines Market Facts & Figures by Type
8.3 Asia Pacific Pediatric Medicines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pediatric Medicines by Country
9.1.1 Latin America Pediatric Medicines Sales by Country
9.1.2 Latin America Pediatric Medicines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pediatric Medicines Market Facts & Figures by Type
9.3 Central & South America Pediatric Medicines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Medicines by Country
10.1.1 Middle East and Africa Pediatric Medicines Sales by Country
10.1.2 Middle East and Africa Pediatric Medicines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pediatric Medicines Market Facts & Figures by Type
10.3 Middle East and Africa Pediatric Medicines Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Pediatric Medicines Products Offered
11.1.5 GSK Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Pediatric Medicines Products Offered
11.2.5 Novartis Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Pediatric Medicines Products Offered
11.3.5 Pfizer Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Pediatric Medicines Products Offered
11.4.5 Sanofi Related Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description and Business Overview
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott Pediatric Medicines Products Offered
11.5.5 Abbott Related Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description and Business Overview
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Pediatric Medicines Products Offered
11.6.5 Bristol-Myers Squibb Related Developments
11.7 Cipla
11.7.1 Cipla Corporation Information
11.7.2 Cipla Description and Business Overview
11.7.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Cipla Pediatric Medicines Products Offered
11.7.5 Cipla Related Developments
11.8 Eisai Pharmaceuticals
11.8.1 Eisai Pharmaceuticals Corporation Information
11.8.2 Eisai Pharmaceuticals Description and Business Overview
11.8.3 Eisai Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eisai Pharmaceuticals Pediatric Medicines Products Offered
11.8.5 Eisai Pharmaceuticals Related Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Description and Business Overview
11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eli Lilly Pediatric Medicines Products Offered
11.9.5 Eli Lilly Related Developments
11.10 F. Hoffman-La Roche
11.10.1 F. Hoffman-La Roche Corporation Information
11.10.2 F. Hoffman-La Roche Description and Business Overview
11.10.3 F. Hoffman-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.10.4 F. Hoffman-La Roche Pediatric Medicines Products Offered
11.10.5 F. Hoffman-La Roche Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Pediatric Medicines Products Offered
11.1.5 GSK Related Developments
11.12 Helsinn Healthcare
11.12.1 Helsinn Healthcare Corporation Information
11.12.2 Helsinn Healthcare Description and Business Overview
11.12.3 Helsinn Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Helsinn Healthcare Products Offered
11.12.5 Helsinn Healthcare Related Developments
11.13 Heron Therapeutics
11.13.1 Heron Therapeutics Corporation Information
11.13.2 Heron Therapeutics Description and Business Overview
11.13.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Heron Therapeutics Products Offered
11.13.5 Heron Therapeutics Related Developments
11.14 Ipca Laboratories
11.14.1 Ipca Laboratories Corporation Information
11.14.2 Ipca Laboratories Description and Business Overview
11.14.3 Ipca Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Ipca Laboratories Products Offered
11.14.5 Ipca Laboratories Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pediatric Medicines Market Estimates and Projections by Region
12.1.1 Global Pediatric Medicines Sales Forecast by Regions 2021-2026
12.1.2 Global Pediatric Medicines Revenue Forecast by Regions 2021-2026
12.2 North America Pediatric Medicines Market Size Forecast (2021-2026)
12.2.1 North America: Pediatric Medicines Sales Forecast (2021-2026)
12.2.2 North America: Pediatric Medicines Revenue Forecast (2021-2026)
12.2.3 North America: Pediatric Medicines Market Size Forecast by Country (2021-2026)
12.3 Europe Pediatric Medicines Market Size Forecast (2021-2026)
12.3.1 Europe: Pediatric Medicines Sales Forecast (2021-2026)
12.3.2 Europe: Pediatric Medicines Revenue Forecast (2021-2026)
12.3.3 Europe: Pediatric Medicines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pediatric Medicines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pediatric Medicines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pediatric Medicines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pediatric Medicines Market Size Forecast by Region (2021-2026)
12.5 Latin America Pediatric Medicines Market Size Forecast (2021-2026)
12.5.1 Latin America: Pediatric Medicines Sales Forecast (2021-2026)
12.5.2 Latin America: Pediatric Medicines Revenue Forecast (2021-2026)
12.5.3 Latin America: Pediatric Medicines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pediatric Medicines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pediatric Medicines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pediatric Medicines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pediatric Medicines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pediatric Medicines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Medicines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pediatric Medicines Market Segments
Table 2. Ranking of Global Top Pediatric Medicines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pediatric Medicines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Enteral
Table 5. Major Manufacturers of Parenteral
Table 6. Major Manufacturers of Topical
Table 7. Global Pediatric Medicines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Pediatric Medicines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Pediatric Medicines Sales by Regions 2015-2020 (K Units)
Table 10. Global Pediatric Medicines Sales Market Share by Regions (2015-2020)
Table 11. Global Pediatric Medicines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pediatric Medicines Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Pediatric Medicines Sales Share by Manufacturers (2015-2020)
Table 14. Global Pediatric Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Pediatric Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Medicines as of 2019)
Table 16. Pediatric Medicines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Pediatric Medicines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Pediatric Medicines Price (2015-2020) (USD/Unit)
Table 19. Pediatric Medicines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Pediatric Medicines Product Type
Table 21. Date of International Manufacturers Enter into Pediatric Medicines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Pediatric Medicines Sales by Type (2015-2020) (K Units)
Table 24. Global Pediatric Medicines Sales Share by Type (2015-2020)
Table 25. Global Pediatric Medicines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Pediatric Medicines Revenue Share by Type (2015-2020)
Table 27. Pediatric Medicines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Pediatric Medicines Sales by Application (2015-2020) (K Units)
Table 29. Global Pediatric Medicines Sales Share by Application (2015-2020)
Table 30. North America Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 31. North America Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 32. North America Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 34. North America Pediatric Medicines Sales by Type (2015-2020) (K Units)
Table 35. North America Pediatric Medicines Sales Market Share by Type (2015-2020)
Table 36. North America Pediatric Medicines Sales by Application (2015-2020) (K Units)
Table 37. North America Pediatric Medicines Sales Market Share by Application (2015-2020)
Table 38. Europe Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 39. Europe Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 40. Europe Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 42. Europe Pediatric Medicines Sales by Type (2015-2020) (K Units)
Table 43. Europe Pediatric Medicines Sales Market Share by Type (2015-2020)
Table 44. Europe Pediatric Medicines Sales by Application (2015-2020) (K Units)
Table 45. Europe Pediatric Medicines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Pediatric Medicines Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Pediatric Medicines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Pediatric Medicines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Pediatric Medicines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Pediatric Medicines Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Pediatric Medicines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Pediatric Medicines Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Pediatric Medicines Sales Market Share by Application (2015-2020)
Table 54. Latin America Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 55. Latin America Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 58. Latin America Pediatric Medicines Sales by Type (2015-2020) (K Units)
Table 59. Latin America Pediatric Medicines Sales Market Share by Type (2015-2020)
Table 60. Latin America Pediatric Medicines Sales by Application (2015-2020) (K Units)
Table 61. Latin America Pediatric Medicines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Pediatric Medicines Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Pediatric Medicines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Pediatric Medicines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Pediatric Medicines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pediatric Medicines Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Pediatric Medicines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Pediatric Medicines Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Pediatric Medicines Sales Market Share by Application (2015-2020)
Table 70. GSK Corporation Information
Table 71. GSK Description and Major Businesses
Table 72. GSK Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. GSK Product
Table 74. GSK Recent Development
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Major Businesses
Table 82. Pfizer Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Product
Table 84. Pfizer Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Major Businesses
Table 87. Sanofi Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Sanofi Product
Table 89. Sanofi Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Major Businesses
Table 92. Abbott Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Abbott Product
Table 94. Abbott Recent Development
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Major Businesses
Table 97. Bristol-Myers Squibb Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bristol-Myers Squibb Product
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Cipla Corporation Information
Table 101. Cipla Description and Major Businesses
Table 102. Cipla Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Cipla Product
Table 104. Cipla Recent Development
Table 105. Eisai Pharmaceuticals Corporation Information
Table 106. Eisai Pharmaceuticals Description and Major Businesses
Table 107. Eisai Pharmaceuticals Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Eisai Pharmaceuticals Product
Table 109. Eisai Pharmaceuticals Recent Development
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Major Businesses
Table 112. Eli Lilly Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Eli Lilly Product
Table 114. Eli Lilly Recent Development
Table 115. F. Hoffman-La Roche Corporation Information
Table 116. F. Hoffman-La Roche Description and Major Businesses
Table 117. F. Hoffman-La Roche Pediatric Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. F. Hoffman-La Roche Product
Table 119. F. Hoffman-La Roche Recent Development
Table 120. Glenmark Corporation Information
Table 121. Glenmark Description and Major Businesses
Table 122. Glenmark Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Glenmark Product
Table 124. Glenmark Recent Development
Table 125. Helsinn Healthcare Corporation Information
Table 126. Helsinn Healthcare Description and Major Businesses
Table 127. Helsinn Healthcare Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Helsinn Healthcare Product
Table 129. Helsinn Healthcare Recent Development
Table 130. Heron Therapeutics Corporation Information
Table 131. Heron Therapeutics Description and Major Businesses
Table 132. Heron Therapeutics Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Heron Therapeutics Product
Table 134. Heron Therapeutics Recent Development
Table 135. Ipca Laboratories Corporation Information
Table 136. Ipca Laboratories Description and Major Businesses
Table 137. Ipca Laboratories Pediatric Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Ipca Laboratories Product
Table 139. Ipca Laboratories Recent Development
Table 140. Global Pediatric Medicines Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global Pediatric Medicines Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Pediatric Medicines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Pediatric Medicines Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Pediatric Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: Pediatric Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Pediatric Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: Pediatric Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Pediatric Medicines Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: Pediatric Medicines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Pediatric Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: Pediatric Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Pediatric Medicines Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: Pediatric Medicines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Pediatric Medicines Players
Table 158. Pediatric Medicines Customers List
Table 159. Pediatric Medicines Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Medicines Product Picture
Figure 2. Global Pediatric Medicines Sales Market Share by Type in 2020 & 2026
Figure 3. Enteral Product Picture
Figure 4. Parenteral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global Pediatric Medicines Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Family
Figure 10. Pediatric Medicines Report Years Considered
Figure 11. Global Pediatric Medicines Market Size 2015-2026 (US$ Million)
Figure 12. Global Pediatric Medicines Sales 2015-2026 (K Units)
Figure 13. Global Pediatric Medicines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Pediatric Medicines Sales Market Share by Region (2015-2020)
Figure 15. Global Pediatric Medicines Sales Market Share by Region in 2019
Figure 16. Global Pediatric Medicines Revenue Market Share by Region (2015-2020)
Figure 17. Global Pediatric Medicines Revenue Market Share by Region in 2019
Figure 18. Global Pediatric Medicines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Pediatric Medicines Revenue in 2019
Figure 20. Pediatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pediatric Medicines Sales Market Share by Type (2015-2020)
Figure 22. Global Pediatric Medicines Sales Market Share by Type in 2019
Figure 23. Global Pediatric Medicines Revenue Market Share by Type (2015-2020)
Figure 24. Global Pediatric Medicines Revenue Market Share by Type in 2019
Figure 25. Global Pediatric Medicines Market Share by Price Range (2015-2020)
Figure 26. Global Pediatric Medicines Sales Market Share by Application (2015-2020)
Figure 27. Global Pediatric Medicines Sales Market Share by Application in 2019
Figure 28. Global Pediatric Medicines Revenue Market Share by Application (2015-2020)
Figure 29. Global Pediatric Medicines Revenue Market Share by Application in 2019
Figure 30. North America Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Pediatric Medicines Sales Market Share by Country in 2019
Figure 33. North America Pediatric Medicines Revenue Market Share by Country in 2019
Figure 34. U.S. Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Pediatric Medicines Market Share by Type in 2019
Figure 39. North America Pediatric Medicines Market Share by Application in 2019
Figure 40. Europe Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Pediatric Medicines Sales Market Share by Country in 2019
Figure 43. Europe Pediatric Medicines Revenue Market Share by Country in 2019
Figure 44. Germany Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Pediatric Medicines Market Share by Type in 2019
Figure 55. Europe Pediatric Medicines Market Share by Application in 2019
Figure 56. Asia Pacific Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Pediatric Medicines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Pediatric Medicines Revenue Market Share by Region in 2019
Figure 60. China Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Pediatric Medicines Market Share by Type in 2019
Figure 83. Asia Pacific Pediatric Medicines Market Share by Application in 2019
Figure 84. Latin America Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Pediatric Medicines Sales Market Share by Country in 2019
Figure 87. Latin America Pediatric Medicines Revenue Market Share by Country in 2019
Figure 88. Mexico Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Pediatric Medicines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Pediatric Medicines Market Share by Type in 2019
Figure 95. Latin America Pediatric Medicines Market Share by Application in 2019
Figure 96. Middle East and Africa Pediatric Medicines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Pediatric Medicines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Pediatric Medicines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Pediatric Medicines Revenue Market Share by Country in 2019
Figure 100. Turkey Pediatric Medicines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Pediatric Medicines Revenue Growth Rate (2015-20
  • 2015-2025 Global Omeprazole Market Research by Type, End-Use and Region (COVID-19 Version)
    Published: 06-Aug-2020        Price: US 2900 Onwards        Pages: 106
    Summary The global Omeprazole market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Production & Consumption Ma......
  • 2015-2025 Global Liver Diseases Therapeutics Drugs Market Research by Type, End-Use and Region (COVID-19 Version)
    Published: 06-Aug-2020        Price: US 2900 Onwards        Pages: 106
    Summary The global Liver Diseases Therapeutics Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Prod......
  • 2015-2025 Global Liver Cirrhosis Therapeutics Drugs Market Research by Type, End-Use and Region (COVID-19 Version)
    Published: 06-Aug-2020        Price: US 2900 Onwards        Pages: 108
    Summary The global Liver Cirrhosis Therapeutics Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Pro......
  • Global Valganciclovir Market Insights and Forecast to 2026
    Published: 06-Aug-2020        Price: US 3900 Onwards        Pages: 110
    Valganciclovir market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Valganciclovir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Valganciclovir market is segmented into - Powder for Solution - Tablet Segment by Applicati......
  • 2015-2025 Global Cough Medicine Market Research by Type, End-Use and Region (COVID-19 Version)
    Published: 05-Aug-2020        Price: US 2900 Onwards        Pages: 101
    Summary The global Cough Medicine market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Production & Consumptio......
  • 2015-2025 Global Antacid Market Research by Type, End-Use and Region (COVID-19 Version)
    Published: 05-Aug-2020        Price: US 2900 Onwards        Pages: 113
    Summary The global Antacid market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size Chapter 2: Global Production & Consumption Market by Type and End-Use Chapter 3: Europe Production & Consumption Market by Type and End-Use Chapter 4: America Production & Consumption Marke......
  • Global Recombinant Vaccines Market Insights and Forecast to 2026
    Published: 05-Aug-2020        Price: US 3900 Onwards        Pages: 117
    Recombinant Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Recombinant Vaccines market is segmented into - Subunit Recombinant Vaccines - Attenuated Reco......
  • Global Corticosteroids Market Insights and Forecast to 2026
    Published: 05-Aug-2020        Price: US 4900 Onwards        Pages: 110
    Corticosteroids market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Corticosteroids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Corticosteroids market is segmented into - Cream - Injection - Other ......
  • Global Primary Immunodeficiency Diseases Treatment Market Research Report 2020 (Covid-19 Version)
    Published: 04-Aug-2020        Price: US 3500 Onwards        Pages: 118
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Immunoglobulin therapy - Antibiotics - Others By Application - Hospitals - Clinics - Others By Company - CSL Behring - Grifols - Pfizer - Takeda - Abbott - ADMA Biologics - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs